WO2025104286 - METHOD AND ARRANGEMENT FOR NON-DESTRUCTIVE CCI TESTING

National phase entry:
Publication Number WO/2025/104286
Publication Date 22.05.2025
International Application No. PCT/EP2024/082556
International Filing Date 15.11.2024
Title **
[English] METHOD AND ARRANGEMENT FOR NON-DESTRUCTIVE CCI TESTING
[French] PROCÉDÉ ET AGENCEMENT DE TEST NON DESTRUCTIF D'INTÉGRITÉ DE FERMETURE DE CONTENANT
Applicants **
NOVO NORDISK A/S
Inventors
CABAÑEROS LÓPEZ, Pau
JAKOBSEN, Peter Westergaard
KARLSMOSE, Agnete Kirstine
KUNOV-KRUSE, Andreas Jonas
PETERSSON, Tino
SALINAS, Iben Secher
STAPPEN, Frederick
Priority Data
23210049.5   15.11.2023   EP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2130
EPO Filing, Examination, Granting8501
Japan Filing, Examination, Granting2170
South Korea Filing, Examination, Granting2060
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 19,601

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention provides a method of, and an arrangement for, testing container closure integrity. The method comprises subjecting a container (10, 30) comprising a transparent wall portion (11, 31) and a drug chamber (17, 37) filled with a liquid drug to a test environment (2) comprising a test gas having at least two atoms in its molecular structure over a period of time sufficient to allow dissolution of any test gas from the test environment (2) in the liquid drug, and, subsequent thereto, obtaining a Raman spectrum of the liquid drug to thereby enable determination of a presence or absence of dissolved test gas in the drug chamber (17, 37).[French] La présente invention concerne un procédé et un agencement pour tester l'intégrité de fermeture de contenant. Le procédé comprend la soumission d'un contenant (10, 30) comprenant une partie de paroi transparente (11, 31) et une chambre de médicament (17, 37) remplie d'un médicament liquide à un environnement de test (2) comprenant un gaz de test avec au moins deux atomes dans sa structure moléculaire sur une période suffisante pour permettre la dissolution de tout gaz de test provenant de l'environnement de test (2) dans le médicament liquide, et, par la suite, l'obtention d'un spectre Raman du médicament liquide pour ainsi permettre la détermination d'une présence ou d'une absence de gaz de test dissous dans la chambre de médicament (17, 37).

Rejoining the server...